Journal article

The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival

Pasquale L Fedele, Yang Liao, Jia-nan Gong, Yuan Yao, Mark F van Delft, Michael SY Low, Lin Tai, Marco J Herold, Jacob T Jackson, Charis E Teh, Tania Tan, Lorraine A O'Reilly, Julie Tellier, George Grigoriadis, David CS Huang, Wei Shi, Stephen L Nutt, Simon N Willis

LEUKEMIA | SPRINGERNATURE | Published : 2020

Grants

Awarded by National Health and Medical Research Council


Awarded by Leukemia & Lymphoma Society-Snowdome Foundation-Leukaemia Foundation (LLS-SF-LF) Translational Research Program (TRP)


Awarded by Leukemia and Lymphoma Society SCOR grant


Awarded by Cancer Council Victoria


Awarded by NHMRC


Awarded by NHMRC/RACP CRB Blackburn scholarship


Funding Acknowledgements

We acknowledge the help of the Walter and Eliza Hall Institute and Flow Cytometry Core Facilities. We also thank Daniel H.D. Gray for helpful discussions. This work was supported by grants from the National Health and Medical Research Council (Project grants 1143105 (MJH), 1128609 (WS); Ideas grant 1184523 (SLN and SNW); Program grant 1113133 (DCSH)), the Leukemia & Lymphoma Society-Snowdome Foundation-Leukaemia Foundation (LLS-SF-LF; 6592-20) Translational Research Program (TRP) (SLN and SNW), the Leukemia and Lymphoma Society SCOR grant 7015-18 (DCSH and MJH), and the Cancer Council Victoria Grant-in-Aid Project grants 1102662 (SLN) and 1161400 (LAO'R). This work was also supported by fellowships awarded to SLN (NHMRC; 1155342), DCSH (NHMRC; 1156024), MJH (NHMRC; 1156095), SNW (Walter and Eliza Hall Trust Centenary Fellowship), PLF (Cancer Council of Victoria Postdoctoral Research Fellowship), MSYL (NHMRC/RACP CRB Blackburn scholarship; 1075151), WS (Walter and Eliza Hall Institute Centenary Fellowship sponsored by Commonwealth Serum Laboratories Limited), and YY (China Scholarship Council).